Sodium chloride
- Generic Name
- Sodium chloride
- Brand Names
- Amphenol-40, As 3, Bi-peglyte, Bicart, Bss, Bss Ophthalmic Solution, Cardioplegic, Citrasate, Clinimix E 2.75/5, Colyte, Corvatrol, Dextrose and Electrolyte No. 75, Dianeal, Dianeal Low Calcium 1.5, Dianeal Pd-2/1.5, Extraneal, Eye Stream, Gavilyte-C, Gavilyte-G, Gavilyte-H and Bisacodyl, Gavilyte-N, Golytely, H.E.L.P.bicel, Hemosate Ultra, Hespan, Hizentra, Hyperlyte, Intersol, Isolyte S, Isolyte S pH 7.4, Isoplate, Lactate 1-2-3, Lactated Ringers, Menopur, Moviprep, Muro 128, Naturalyte, Normosol-M, Normosol-R, Nulytely, Nxstage Pureflow, P-Care M, P-Care MG, P-care, P-care X, Peglyte, Phoxillum, Physiolyte, Physioneal 40, Physiosol, Plasma-lyte, Plasma-lyte 148, Plasma-lyte 148 In 5 % Dextrose, Plasma-lyte R, Plasmalyte A, Plegisol, Plenvu, Prismasol, Procalamine 3, Ringers, Sag-M, Sclerodex, Suflave, Tis-U-sol
- Drug Type
- Small Molecule
- Chemical Formula
- ClNa
- CAS Number
- 7647-14-5
- Unique Ingredient Identifier
- 451W47IQ8X
- Background
Sodium chloride, also known as salt, common salt, table salt or halite, is an ionic compound with the chemical formula NaCl, representing a 1:1 ratio of sodium and chloride ions. Sodium chloride is the primary salt in seawater and in the extracellular fluid of many multicellular organisms. It is listed on the World Health Organization Model List of Essential...
- Indication
This intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration. Also, designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives.
- Associated Conditions
- Allergic Rhinitis (AR), Corneal Edema, Dehydration, Dehydration Hypertonic, Fluid Loss, Hemodilution, Hypokalemia, Hyponatremia, Hypotonic Dehydration, Hypovolaemia, Increase in Intracranial Pressure (ICP), Increased Intra Ocular Pressure (IOP), Inflammation of the Nasal Mucosa, Isotonic Dehydration, Metabolic Acidosis, Nasal Congestion, Nasal irritation, Oliguria caused by Acute Renal Failure (ARF), Potassium deficiency, Sinusitis, Skin Irritation, Sodium Depletion, Dryness of the nose, Hypochloremic state, Mild Metabolic acidosis, Mild, moderate Metabolic Acidosis
- Associated Therapies
- Electrolyte replacement, Fluid replacement therapy, Heart-Lung-Machine, Oral rehydration therapy, Parenteral Nutrition, Parenteral rehydration therapy, Peritoneal dialysis therapy, Plasma Volume Replacement, Regional Citrate Anticoagulation (RCA), Renal Replacement Therapies, Urine alkalinization therapy, Wound irrigation therapy, Ear wax removal, Fluid and electrolyte maintenance therapy, Increased renal excretion of toxic substances, Maintenance source of fluid and electrolytes, Parenteral drug administration, Reducing brain mass
FITMI - First In Treating Male Infertility
- Conditions
- Interventions
- First Posted Date
- 2022-01-28
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Martin Blomberg Jensen
- Target Recruit Count
- 180
- Registration Number
- NCT05212337
- Locations
- 🇩🇰
Department of Growth and Reproduction, Rigshospitalet, Copenhagen, Denmark
A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study.
- Conditions
- Interventions
- First Posted Date
- 2022-01-06
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Sean Liu
- Target Recruit Count
- 35
- Registration Number
- NCT05181709
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
A Study of Two Formulations (Both Refrigerated and Room Temperature) Using an Autoinjector Device in Healthy Participants
- Conditions
- Interventions
- First Posted Date
- 2021-12-13
- Last Posted Date
- 2022-01-13
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 44
- Registration Number
- NCT05154968
- Locations
- 🇨🇦
Syneos Health, Québec, Canada
VAsopressin and STeroids in Addition to Adrenaline in Cardiac Arrest - a Randomized Clinical Trial
- First Posted Date
- 2021-12-01
- Last Posted Date
- 2022-01-20
- Lead Sponsor
- Tiohundra AB
- Target Recruit Count
- 1276
- Registration Number
- NCT05139849
- Locations
- 🇸🇪
Tiohundra, Norrtälje, Sweden
🇸🇪Sahlgrenska University Hospital, Gothenburg, Sweden
The PREVENT AGITATION Trial II - Children ≤1 Year
- First Posted Date
- 2021-10-25
- Last Posted Date
- 2024-04-11
- Lead Sponsor
- Rigshospitalet, Denmark
- Target Recruit Count
- 336
- Registration Number
- NCT05091242
- Locations
- 🇩🇰
Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
Pre-operative Enoxaparin in the Surgical Management of Multi-trauma Patients Undergoing Orthopedic Surgical Procedures
- Conditions
- Interventions
- First Posted Date
- 2021-10-18
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- Valleywise Health
- Target Recruit Count
- 6
- Registration Number
- NCT05081375
- Locations
- 🇺🇸
Valleywise Health, Phoenix, Arizona, United States
Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled APN01 Developed as Treatment for COVID-19
- Conditions
- Interventions
- First Posted Date
- 2021-10-04
- Last Posted Date
- 2022-09-23
- Lead Sponsor
- Apeiron Biologics
- Target Recruit Count
- 40
- Registration Number
- NCT05065645
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites
- Conditions
- Interventions
- First Posted Date
- 2021-09-24
- Last Posted Date
- 2024-06-24
- Lead Sponsor
- Aleksander Krag
- Target Recruit Count
- 240
- Registration Number
- NCT05056220
- Locations
- 🇭🇺
Debreceni Egyetem, Debrecen, Hungary
🇳🇱Academisch Ziekenhuis Leiden, Leiden, Netherlands
🇳🇱Alrijne Ziekenhuis Leiden, Leiderdorp, Netherlands
Dexmedetomidine or Clonidine Infusion for Prevention of Delirium After Open Heart Surgery
- Conditions
- Interventions
- First Posted Date
- 2021-08-31
- Last Posted Date
- 2024-04-30
- Lead Sponsor
- Oslo University Hospital
- Target Recruit Count
- 900
- Registration Number
- NCT05029050
- Locations
- 🇳🇴
Oslo University Hospital Rikshospitalet, Oslo, Norway
🇳🇴Oslo University Hospital Ullevål, Oslo, Norway
🇳🇴University Hospital of North Norway, Tromsø, Norway
Zoledronate Early to Hip Fracture Patients - Safe and Effective?
- Conditions
- Interventions
- First Posted Date
- 2021-08-27
- Last Posted Date
- 2024-04-02
- Lead Sponsor
- Lene Bergendal Solberg
- Target Recruit Count
- 300
- Registration Number
- NCT05025293
- Locations
- 🇳🇴
Oslo University Hospital, Oslo, Norway
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.